Two new colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 44, Issue 2, 2006, Pages 580-582

  Coban, Ahmet Y ^a   Bozdogan, Bülent ^b   Cihan, Cigdem Cekic ^a   Cetinkaya, Ebru ^a   Bilgin, Kemal ^a   Darka, Ozge ^a   Akgunes, Alper ^a   Durupinar, Belma ^a   Appelbaum, Peter C ^c  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE REDUCTASE; OXACILLIN; RESAZURIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; EARLY DIAGNOSIS; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COLORIMETRY; HUMANS; MICROBIAL SENSITIVITY TESTS; NITRATE REDUCTASE; OXACILLIN; OXAZINES; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE; XANTHENES;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 32344449455     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.2.580-582.2006     Document Type: Article

References (12)

1. Arbique, J., K. Forward, D. Haldane, and R. Davidson. 2001. Comparison of the Velogene Rapid MRSA identification assay, Denka MRSA-Screen assay, and BBL Crystal MRSA ID system for rapid identification of methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 40:5-10.
2. Baker, C. N., and F. C. Tenover. 1996. Evaluation of alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci. J. Clin. Microbiol. 34:2654-2659.
3. Bozdogan, B., L. Ednie, K. Credito, K. Kosowska, and P. C. Appelbaum. 2004. Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center. Antimicrob. Agents Chemother. 48:4762-4765.
4. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb. Mortal. Wkly. Rep. 51:565-567.
5. Centers for Disease Control and Prevention. 2002. Public health dispatch: vancomycin-resistant Staphylococcus aureus-Pennsylvania, 2002. Morb. Mortal. Wkly. Rep. 51:902.
6. Centers for Disease Control and Prevention. 2004. Brief report: vancomycin-resistant Staphylococcus aureus-New York, 2004. Morb. Mortal. Wkly. Rep. 53:322-323.
7. Ferraro, M. J., and J. H. Jorgensen. 2003. Susceptibility testing instrumentation and computerized expert systems for data analysis and interpretation, p. 208-217. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
8. Food and Drug Administration. 2003. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry and FDA. [Online.] http://www.fda.gov/cdrh/ode/631.pdf.
9. Howden, B. P., P. B. Ward, P. D. R. Johnson, P. G. P. Charles, and M. L. Grayson. 2005. Low-level vancomycin resistance in Staphylococcus aureus-an Australian perspective. Eur. J. Clin. Microbiol. Infect. Dis. 24:100-108.
10. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Tunney, M. M., G. Ramage, T. T. Field, T. F. Moriarty, and D. G. Storey. 2004. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:1879-1881.
12. Whitener, C. J., S. V. Park, F. A. Browne, L. J. Parent, K. Julian, B. Bozdogan, et al. 2004. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin. Infect. Dis. 38:1049-1055.